ArticlePloS one2022

Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.

Margaret L Musser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.